Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)

Clinical trial NCT01441401 · COMPLETED

Trial details

NCT number: NCT01441401
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Epilepsies, Partial

Start date: 2011-12-01
Primary completion: 2014-08-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.